Purpose of Review To describe potential antimicrobial stewardship program strategies to enhance the optimization of antimicrobial therapy for patients with cystic fibrosis (CF). Recent Findings Cystic fibrosis is a complex medical condition known for its frequent pulmonary exacerbations attributed to microorganisms which are treated with antimicrobials administered by various routes. Due to exposure to antimicrobials from an early age, both as eradication regimens and for chronic colonization, this patient population often has drug-resistant organisms colonizing their respiratory tract. With CF patients surviving well into adulthood, preservation of antimicrobials is more essential now than ever. Antimicrobial stewardship programs have been shown to optimize antimicrobial use in the hospital and outpatient setting, but interventions applied to CF patients are not as well documented. For hospitalized patients, stewardship programs develop antibiotic dosing and monitoring guidelines and treatment algorithms. In addition to these approaches, the CF population may benefit from review of different routes or methods of administration of antimicrobials to optimize pharma- cokinetics and pharmacodynamics. These include inhaled antibiotics and prolonged infusions. Summary In the CF population that is exposed to frequent courses of antimicrobials, we propose that collaboration with a stewardship program to engage in optimization of antimi- crobial administration would
Current Treatment Options in Infectious Diseases – Springer Journals
Published: Apr 25, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud